COVID-19 More Severe in Veterans With Chronic Lung Diseases

Veterans with chronic lung diseases, particularly idiopathic pulmonary fibrosis (IPF), other interstitial lung diseases (ILD) and chronic obstructive pulmonary disease (COPD), have an increased risk of experiencing more severe 30-day outcomes with COVID-19, according to a recent study.

Tixagevimab/Cilgavimab Found Effective in Immunocompromised Veterans

The risk of COVID-19 morbidity and mortality is much higher for immunocompromised patients, and, while vaccines have been highly successful at preventing the spread of SARS-CoV-2 and decreasing the likelihood of severe disease in the general population, those who are immunocompromised still face a greater danger for breakthrough infections and persistent viral replication, according to a new study.